OrthoPediatrics Corp. ( KIDS ) NASDAQ Global Market

Cena: 20.53 ( 1.18% )

Aktualizacja 06-23 21:17
NASDAQ Global Market
Branża: Medical - Devices

Notowania:


Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Devices
Zatrudnienie: 247
Giełda: NASDAQ Global Market
Ilość akcji w obrocie: 67%
Ilość akcji: 23 355 100
Debiut giełdowy: 2017-10-13
WWW: https://www.orthopediatrics.com
CEO: Mr. David R. Bailey
Adres: 2850 Frontier Drive
Siedziba: 46582 Warsaw
ISIN: US68752L1008
Opis firmy:

Orthopediatrics Corp., firma zajmująca się urządzeniami medycznymi, projektuje, rozwija i sprzedaje anatomicznie odpowiednie implanty i urządzenia do leczenia dzieci z warunkami ortopedycznymi w Stanach Zjednoczonych i na arenie międzynarodowej. Firma oferuje produkty do korekty urazów i deformacji; Procedury skoliozy dotyczące leczenia deformacji kręgosłupa; oraz medycyna sportowa i inne produkty. Jego produkty zawierają pediloc, pediplaty, śruby kaniulowane, paznokcie pediflex, pedinail, piszczelowe kisze, przednie systemy rekonstrukcji więzadeł krzyżowych, blokujące łopatki kanipingowe, blokujące proksymalne stoliki, SPICIX STABLES, Systemy kręgosłupa reagowania, bandloc, pediguard, pediatryczna platforma paznokci, pediatryczna, femur, systemu femur, orthex i apifix. Firma obsługuje pediatryczny rynek ortopedyczny, a także chirurgów ortopedycznych pediatrycznych i opiekunów. Orthopediatrics Corp. został założony w 2006 roku i ma siedzibę w Warszawie w stanie Indiana.

Wskaźniki finansowe
Kapitalizacja (USD) 508 495 185
Aktywa: 489 294 000
Cena: 20.53
Wskaźnik Altman Z-Score: 2.9
Umiarkowany (ryzyko bankructwa średnie)
Dywidenda: 0
P/E: -11.7
Ilość akcji w obrocie: 67%
Średni wolumen: 145 251
Ilość akcji 24 769 000
Wskaźniki finansowe
Przychody TTM 189 673 000
Zobowiązania: 118 375 000
Przedział 52 tyg.: 19.515 - 35.99
Piotroski F-Score: 2
Słaby (niska jakość finansowa)
EPS: -1.8
P/E branży: 26.8
Beta: 1.163
Raport okresowy: 2025-08-04
WWW: https://www.orthopediatrics.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. David R. Bailey President, Chief Executive Officer & Director 877 888 1979
Mr. Fred L. Hite Chief Financial Officer, Principal Financial & Accounting Officer, Chief Operating Officer and Director 791 419 1968
Mr. Joseph W. Hauser President of Trauma & Deformity Correction 537 995 1983
Mr. Gregory A. Odle President of Scoliosis 537 995 1970
Mr. Daniel J. Gerritzen Executive Vice President of Legal, General Counsel & Secretary 537 995 1970
Mr. Kevin L. Unger CHE, MBA/MSHA President of Enabling Technologies 22 500 1972
Mr. Mark Karshner Senior Vice President of International Sales 0 0
Mr. Mark C. Throdahl Executive Chairman 0 1951
Mr. Joel Batts Senior Vice President of Clinical & Regulatory Affairs 0 0
Wiadomości dla OrthoPediatrics Corp.
Tytuł Treść Źródło Aktualizacja Link
GRAMMY® AWARD-WINNING, MULTIPLATINUM GLOBAL SUPERSTAR TYLA TO HOST NICKELODEON KIDS' CHOICE AWARDS 2025--THE BIGGEST PARTY OF THE SUMMER --LIVE ON SATURDAY, JUNE 21, AT 8 P.M. (ET/PT) Benson Boone, Jack Black, Ariana Grande, Cynthia Erivo, Chris Evans, Selena Gomez, Jalen Hurts, Travis Kelce, Kendrick Lamar, Peyton List, Jason Momoa, MrBeast, Jenna Ortega, Keanu Reeves, Taylor Swift, Charli XCX and More, Announced as KCA Nominees Share It: @Nickelodeon @KidsChoiceAwards #KCA Click  HERE  to download photos and HERE  to embed video. HOLLYWOOD, Calif. prnewswire.com 2025-05-15 13:06:00 Czytaj oryginał (ang.)
KROGER PARTNERING WITH THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) TO HELP KIDS WITH BLOOD CANCER Funds Raised in North Texas and Louisiana to Benefit the Work of LLS's The Dare to Dream Project to Bring Safer, Less Toxic Treatments for Kids with Blood Cancer & Provide Free Support & Resources for Their Families DALLAS , May 14, 2025 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) has partnered with Kroger's Dallas Division to raise funds in North Texas and Louisiana in support of The Dare to Dream Project. LLS is working to transform treatment and care for pediatric blood cancer patients and funds raised at participating Kroger locations will exclusively benefit the life-saving work of The Dare to Dream Project and will help LLS achieve its goal to ensure kids receive the blood cancer treatments live longer, better lives. prnewswire.com 2025-05-14 13:00:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting WARSAW, Ind., May 14, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the 2025 Pediatric Orthopaedic Society of North America (“POSNA”) annual meeting as an Emerald Sponsor. globenewswire.com 2025-05-14 11:00:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. (KIDS) Q1 2025 Earnings Call Transcript OrthoPediatrics Corp. (NASDAQ:KIDS ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group, IR David Bailey - President and CEO Fred Hite - Chief Operating and Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Ryan Zimmerman - BTIG Rick Wise - Stifel Ben Haynor - Lake Street Capital Markets Operator Good day and thank you for standing by. Welcome to the OrthoPediatrics Corporation First Quarter 2025 Earnings Conference call. seekingalpha.com 2025-05-11 06:25:15 Czytaj oryginał (ang.)
OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com 2025-05-07 23:00:33 Czytaj oryginał (ang.)
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates OrthoPediatrics (KIDS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.30 per share a year ago. zacks.com 2025-05-07 22:45:41 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025. globenewswire.com 2025-05-07 20:05:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its Trauma and Deformity portfolio with 3P™ Pediatric Plating Platform™ Hip System, the first of several systems in the 3P family. This represents the company's 5th FDA approval in 2025. globenewswire.com 2025-05-07 20:01:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System WARSAW, Ind., April 08, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat Early Onset Scoliosis (“EOS”). This represents the company's 80th system designed to treat musculoskeletal issues in children. globenewswire.com 2025-04-08 12:05:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference WARSAW, Ind., March 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference. globenewswire.com 2025-03-25 18:05:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana WARSAW, Ind., March 24, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was selected as one of the 2025 Best Places to Work in Indiana. This is the 9th time the Company has been recognized by the annual program created by the Indiana Chamber of Commerce. globenewswire.com 2025-03-24 18:05:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company's cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.​ globenewswire.com 2025-03-17 18:05:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. (KIDS) Q4 2024 Earnings Call Transcript OrthoPediatrics Corp. (NASDAQ:KIDS ) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group, IR David Bailey - President and CEO Fred Hite - Chief Operating and Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Rick Wise - Stifel Matthew O'Brien - Piper Sandler Joseph Conway - Needham & Company Operator Hello. And welcome to OrthoPediatrics Corporation's Fourth Quarter and Full Year 2024 Earnings Conference Call. seekingalpha.com 2025-03-04 22:15:18 Czytaj oryginał (ang.)
Compared to Estimates, OrthoPediatrics (KIDS) Q4 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2025-03-04 21:00:26 Czytaj oryginał (ang.)
OrthoPediatrics (KIDS) Reports Q4 Loss, Misses Revenue Estimates OrthoPediatrics (KIDS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.23 per share a year ago. zacks.com 2025-03-04 20:20:32 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results Record full year 2024 revenue of $204.7 million increased 38% compared to prior year, and more than doubled fourth quarter 2024 adjusted EBITDA WARSAW, Ind., March 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the fourth quarter and full year ended December 31, 2024. globenewswire.com 2025-03-04 18:05:00 Czytaj oryginał (ang.)
SOUR PATCH KIDS® Introduces Glow Ups: The First-Ever Gummy Candy that Glows Under Blacklight The brand's latest innovation features edible confetti containing turmeric extract, which gives it an unforgettable glow EAST HANOVER, N.J. , March 4, 2025 /PRNewswire/ -- The SOUR PATCH KIDS brand is lighting up the candy aisle with its latest innovation: SOUR PATCH KIDS Strawberry-Watermelon Glow Ups, the first-ever gummy candy that glows under blacklight. prnewswire.com 2025-03-04 11:00:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 WARSAW, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, March 4, 2025 at 4:30 p.m. ET to discuss the results. globenewswire.com 2025-02-19 10:05:00 Czytaj oryginał (ang.)
POTTERY BARN KIDS EXPANDS POPULAR MODERN BABY COLLECTION SAN FRANCISCO--(BUSINESS WIRE)--Pottery Barn Kids, a portfolio brand of Williams-Sonoma, Inc. (NYSE: WSM), the world's largest digital-first, design-led and sustainable home retailer, announced today the expansion of the brand's popular Modern Baby collection with 14 design-forward lifestyles. The Modern Baby collection offers distinct aesthetics that each uniquely embrace modern elements of design for a style that is warm and welcoming, while maintaining the brand's signature quality and safet. businesswire.com 2025-02-13 19:35:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing solutions to the US market through its OrthoPediatrics Specialty Bracing (OPSB) division. globenewswire.com 2025-01-22 10:05:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance Achieves all-time high full year 2024 Revenue of $205 million representing growth of 38% Year-Over-YearInitiates guidance for record adjusted EBITDA in 2025 globenewswire.com 2025-01-13 18:00:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division WARSAW, Ind., Jan. 10, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the rapid expansion of its Specialty Bracing (OPSB) division with entrance into 3 target markets within Indiana, Colorado, and Florida. globenewswire.com 2025-01-10 10:05:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Products WARSAW, Ind., Dec. 05, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics today announced that the OrthoPediatrics Specialty Bracing (OPSB™) division is expanding its product offering with the launch of two new products including the OPSB Sensor System and MOVE-D™. globenewswire.com 2024-12-05 10:05:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. to Host Educational and Networking Events at 20th Annual International Pediatric Orthopaedic Symposium (IPOS) WARSAW, Ind., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host educational and networking events at IPOS and its continued support of the event as an Emerald-Level sponsor. globenewswire.com 2024-12-02 18:05:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace WARSAW, Ind., Nov. 26, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company dedicated exclusively to advancing the field of pediatric orthopedics, is excited to announce significant updates to the DF2® Brace, a cornerstone product within the OrthoPediatrics Specialty Bracing business (“OPSB”). The DF2 Brace updates include expanded indications for use, enhanced sizing options, and additional international markets. globenewswire.com 2024-11-26 18:05:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. (KIDS) Q3 2024 Earnings Call Transcript OrthoPediatrics Corp. (NASDAQ:KIDS ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Trip Taylor - Gilmartin Group David Bailey - President & Chief Executive Officer Fred Hite - Chief Financial Officer & Chief Operating Officer Conference Call Participants Matt O'Brien - Piper Sandler Joseph Conway - Needham & Company Operator Good morning and welcome to OrthoPediatrics Corporation's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com 2024-11-08 17:16:33 Czytaj oryginał (ang.)
Compared to Estimates, OrthoPediatrics (KIDS) Q3 Earnings: A Look at Key Metrics The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. zacks.com 2024-11-06 21:36:26 Czytaj oryginał (ang.)
OrthoPediatrics (KIDS) Reports Q3 Loss, Tops Revenue Estimates OrthoPediatrics (KIDS) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.13 per share a year ago. zacks.com 2024-11-06 21:00:59 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance WARSAW, Ind., Nov. 06, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2024. globenewswire.com 2024-11-06 18:05:00 Czytaj oryginał (ang.)
KAMALA HARRIS NAMED WINNER OF NICKELODEON'S KIDS PICK THE PRESIDENT "KIDS' VOTE" POLL BRAND-NEW KIDS PICK THE PRESIDENT SPECIAL, HOSTED BY NATE BURLESON AND HIS DAUGHTER MIA, DEBUTS TONIGHT AT 8 P.M. (ET/PT) ON NICKELODEON PLATFORMS AND PARAMOUNT+ Share it: @Nickelodeon #KidsPickthePresident Click HERE  to download assets. prnewswire.com 2024-10-28 15:00:00 Czytaj oryginał (ang.)
OrthoPediatrics Corp. to Report Third Quarter 2024 Financial Results on November 7, 2024 WARSAW, Ind., Oct. 23, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2024 financial results on Wednesday, November 6, 2024, after the market closes. OrthoPediatrics will host a conference call on Thursday, November 7, 2024, at 8:00 a.m. ET to discuss the results. globenewswire.com 2024-10-23 20:05:00 Czytaj oryginał (ang.)
What Makes OrthoPediatrics (KIDS) a New Strong Buy Stock OrthoPediatrics (KIDS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com 2024-10-17 17:01:24 Czytaj oryginał (ang.)
POTTERY BARN, POTTERY BARN KIDS AND POTTERY BARN TEEN LAUNCH COLLABORATIONS WITH HUSBAND-AND-WIFE DUO, CHRIS LOVES JULIA SAN FRANCISCO--(BUSINESS WIRE)--Pottery Barn, Pottery Barn Kids and Pottery Barn Teen, portfolio brands of Williams-Sonoma, Inc. (NYSE: WSM), the world's largest digital-first, design-led and sustainable home retailer, announced today, new home furnishings collections with Chris and Julia Marcum, of the popular design blog, Chris Loves Julia. Predicated on the success of the Chris Loves Julia collaboration for Pottery Barn Kids that launched in 2023, the design duo has expanded their collaborat. businesswire.com 2024-10-10 12:00:00 Czytaj oryginał (ang.)
Down -15.65% in 4 Weeks, Here's Why You Should You Buy the Dip in OrthoPediatrics (KIDS) OrthoPediatrics (KIDS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. zacks.com 2024-10-03 14:36:10 Czytaj oryginał (ang.)
NICKELODEON LETS KIDS' VOICES BE HEARD THIS ELECTION SEASON WITH RETURN OF KIDS PICK THE PRESIDENT "KIDS' VOTE" POLL AND BRAND-NEW SPECIAL NICK'S "KIDS' VOTE" LAUNCHES TODAY, WITH RESULTS REVEALED IN SPECIAL HOSTED BY NATE BURLESON AND HIS DAUGHTER MIA, DEBUTING MONDAY, OCT. 28, ON NICKELODEON PLATFORMS AND PARAMOUNT+ Share it: @Nickelodeon #KidsPickthePresident Click HERE  to download asset. prnewswire.com 2024-10-03 12:00:00 Czytaj oryginał (ang.)
Bears are Losing Control Over OrthoPediatrics (KIDS), Here's Why It's a 'Buy' Now OrthoPediatrics (KIDS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term. zacks.com 2024-09-25 14:55:15 Czytaj oryginał (ang.)
Does OrthoPediatrics (KIDS) Have the Potential to Rally 36.3% as Wall Street Analysts Expect? The average of price targets set by Wall Street analysts indicates a potential upside of 36.3% in OrthoPediatrics (KIDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. zacks.com 2024-09-17 14:55:23 Czytaj oryginał (ang.)
MY GYM AND SKECHERS LAUNCH SKECHERS KIDS MONTH The September event is offering young families fun activities and giveaways featuring the footwear brand's Skechers Hands Free Slip-ins ®  collection for kids SHERMAN OAKS, Calif. , Sept. 17, 2024 /PRNewswire/ -- My Gym, the premier destination for children's fitness, has partnered with Skechers to offer families the brands' first-ever Skechers Kids Month. prnewswire.com 2024-09-17 13:03:00 Czytaj oryginał (ang.)
KIDS Stock Gains From Its New Enabling Technologies Division Launch OrthoPediatrics recently launched its Enabling Technologies division, set to generate sustainable revenue growth and gain access to new markets and specialties beyond orthopedics. zacks.com 2024-09-16 12:51:07 Czytaj oryginał (ang.)
OrthoPediatrics Corp. Announces Launch of Enabling Technologies Division Additional details to be discussed during the Company's Investor Day today, September 12, 2024 Additional details to be discussed during the Company's Investor Day today, September 12, 2024 globenewswire.com 2024-09-12 11:05:00 Czytaj oryginał (ang.)
Wall Street Analysts Predict a 31.2% Upside in OrthoPediatrics (KIDS): Here's What You Should Know The consensus price target hints at a 31.2% upside potential for OrthoPediatrics (KIDS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com 2024-08-29 14:55:42 Czytaj oryginał (ang.)
OrthoPediatrics Corp. to Host Investor Day on September 12, 2024 WARSAW, Ind., Aug. 20, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced plans to host an investor day at 10:30am E.T. on September 12, 2024, in New York, New York. Management's presentation will provide updates on the Company's Specialty Bracing business strategy, product pipeline, and financial outlook and feature a KOL surgeon panel. globenewswire.com 2024-08-20 20:05:00 Czytaj oryginał (ang.)